The Data Are Clear: Patients Regain Weight After Stopping GLP-1 Drugs
(MedPage Today) — This story is part of a series called “Ozempic: Weighing the Risks and Benefits.” It was produced in part through a grant from the NIHCM Foundation.
Looking at the data from clinical trials of new GLP-1 agonists, it’s clear…
GLP-1 Agent May Hold Opioid Use Disorder Benefit
(MedPage Today) — Semaglutide (Ozempic, Wegovy) may help reduce the risk of an opioid overdose in certain people, an emulation target trial suggested.
Over a 1-year follow-up, people with comorbid type 2 diabetes and opioid use disorder (OUD…
Saving time with AI-generated treatment plans for breast cancer
Drawing in the organs of individual breast cancer patients and then creating precise radiation plans appears to be faster by using artificial intelligence (AI) models. That way, it remains just as reliable and accurate. It saves considerable time per patient—a pleasant conclusion with current health care developments in mind.
Ozempic could even help prevent opioid overdoses, study says
Novo Nordisk’s blockbuster drug Ozempic may offer yet another health benefit: helping to curb overdoses.Read more…
Treatment Cost Not Tied to Survival in Breast Cancer
A new study analyzed 26 breast cancer drugs approved by the FDA between 2000 and 2023. Medscape Medical News
Ozempic for opioid addiction and Apple Watches for sleep apnea
Today’s health news includes new research on Ozempic and drug overdose risk and on using MRIs to diagnose prostate cancer.
AI could predict breast cancer risk via ‘zombie cells’
Women worldwide could see better treatment with new AI technology, which enables better detection of damaged cells and more precisely predicts the risk of getting breast cancer, shows new research from the University of Copenhagen.
Semaglutide improves outcomes for obese patients with common skin condition, new study shows
A pioneering study, presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in people with obesity.
Ozempic is bridging the political divide
The health benefits of blockbuster weight loss drugs are bridging the stark political divide in the United States. Read more…
Ozempic linked to lower opioid overdose rate in those with diabetes, study shows
“The preliminary findings from this study point to the possibility that GLP-1 medications may have value in helping to prevent opioid overdoses.”